Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2005
10/05/2005CN1676530A Matrimony vine arabinogalactan protein, and its preparing process, use and composition
10/05/2005CN1676164A Colon positioned-release oral insulin self-micro emulsion formulation and capsule containing it
10/05/2005CN1676163A Human glucagon-like peptide-1 compound and its preparing method
10/05/2005CN1676162A Thymic penta peptide injection liquid
10/05/2005CN1221663C High effective expression of recombined human internal inhibition factor
10/05/2005CN1221570C Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
10/05/2005CN1221569C Cell surface molecule mediating cell adhesion and signal transmission
10/05/2005CN1221568C Composition and methods for detecting and treating acquired immunodeficiency syndrome
10/05/2005CN1221566C gClq receptor jointed HIV-lgp120 relative peptide and coded oligonucleotide thereof
10/05/2005CN1221565C Peptides and their derivatives thereof showing cell attachment, spreading and detachment activity
10/05/2005CN1221284C Medicine for treating diabetes
10/05/2005CN1221283C Oral insulin granule and its preparation
10/05/2005CN1221282C Total hormone replacement therapy
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/05/2005CN1221246C Use of medicine having chemical compound for promoting collagen synthesizing activity
10/04/2005US6951955 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
10/04/2005US6951939 Multivalent platform molecules comprising high molecular weight polyethylene oxide
10/04/2005US6951927 Proteins with integrin-like activity
10/04/2005US6951926 Antibody to bladder cancer nuclear matrix protein and its use
10/04/2005US6951924 Antibodies against secreted protein HTEBYII
10/04/2005US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
10/04/2005US6951921 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins; extracellular
10/04/2005US6951919 which functions as an antagonist or apoptosis-inducing activity regulator; tumor necrosis factors; membrane proteins; reduced sensitivity to proteases/metalloproteases
10/04/2005US6951918 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
10/04/2005US6951917 major histocompatability complex (MHC-class II); human leukocyte antigen; recognized by CD4 lymphocytes; immunogens; vaccines; immunotherapy
10/04/2005US6951916 Melanocortin receptor ligands
10/04/2005US6951915 Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
10/04/2005US6951854 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
10/04/2005US6951850 Dipeptide derivatives
10/04/2005US6951845 Method for treating allergic lung disease
10/04/2005US6951843 Peptide derivatives and their pharmaceutically acceptable salts, thereof, processes for preparation of both and use thereof
10/04/2005US6951842 solubilizing compound comprising a guanidinium group provides high concentrations of soluble insulin-like growth factor at pH 5 to 9 and at refrigerated temperatures
10/04/2005US6951841 Bioavailability; side effect reduction
10/04/2005US6951840 Peptidase inhibitor; bactericides
10/04/2005US6951839 Methods and compositions for regulating lymphocyte activity
10/04/2005US6951755 Vectors and methods for gene transfer
10/04/2005US6951739 Calcium channel modulators; animal husbandry; fish breeding
10/04/2005US6951738 Human tumor necrosis factor receptors TR13 and TR14
10/04/2005US6951735 Death domain containing receptors
10/04/2005US6951732 Virulence genes, proteins, and their use
10/04/2005US6951721 Monitoring gene expression in cells; obtain cells, isolate genomic nucleotide sequences, determine genotype, determine the frequency of the genotype in cell pool, evaluate pattern of frequency
10/04/2005US6951717 Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
10/04/2005US6951655 Comprises liposome core containing drugs (insulin) encapsulated within fatty acid membrane
10/04/2005US6951653 Streptococcal C5a peptidase vaccine
10/04/2005US6951219 Treatment of hepatitis C using hyperthermia
10/04/2005CA2185661C Novel iron chelator and inhibitor of iron-mediated oxidation
10/04/2005CA2166101C Drug delivery
10/04/2005CA2117761C Pharmaceutical compositions containing il-6
10/04/2005CA2105304C Inhibitors of human neutrophil elastase and human cathepsin g
10/02/2005CA2461375A1 Cea binding agents compositions to reverse cea-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof
09/2005
09/30/2005CA2503332A1 Bone substitute
09/29/2005WO2005090995A2 Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility
09/29/2005WO2005090977A1 C20orf23 as modifier of the igfr pathway and methods of use
09/29/2005WO2005090976A1 Pdes as modifiers of the igfr pathway and methods of use
09/29/2005WO2005090974A1 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
09/29/2005WO2005090968A1 Tat-based immunomodulatory compositions and methods of their discovery and use
09/29/2005WO2005090579A1 Modified bouganin proteins, cytotoxins and methods and uses thereof
09/29/2005WO2005090576A1 Dna construct for preventing pertussis infection
09/29/2005WO2005090575A1 Glycosylation variants of ricin-like proteins
09/29/2005WO2005090574A1 Vascular endothelial growth inhibiting gene
09/29/2005WO2005090573A2 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
09/29/2005WO2005090571A1 Vglut-specific dsrna compounds
09/29/2005WO2005090570A1 Therapeutic compositions and methods for treating diseases that involve angiogenesis
09/29/2005WO2005090564A1 Gene promoting vascular endothelial cell growth
09/29/2005WO2005090402A1 Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same
09/29/2005WO2005090400A1 Immunosuppressive cytokine
09/29/2005WO2005090398A1 Genes and polypeptides relating to prostate cancers
09/29/2005WO2005090396A1 Novel mannose-specific adhesins and their use
09/29/2005WO2005090395A2 Methods for increasing protein polyethylene glycol (peg) conjugation
09/29/2005WO2005090393A2 Multimeric protein toxins to target cells having multiple identifying characteristics
09/29/2005WO2005090392A1 Tat-based tolerogen compositions and methods of making and using same
09/29/2005WO2005090389A2 Isosteric transformation
09/29/2005WO2005090388A1 Alpha helical mimics, their uses and methods for their production
09/29/2005WO2005090386A1 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
09/29/2005WO2005090385A2 Compositions having antimicrobial activity and uses thereof
09/29/2005WO2005090383A2 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections
09/29/2005WO2005090382A1 Antithrombotic compound
09/29/2005WO2005090378A1 Ligands of the molecule fit (agt-121) and their pharmaceutical use
09/29/2005WO2005089826A1 Bone graft and scaffolding materials immobilized with osteogenesis enhancing peptides on the surface
09/29/2005WO2005089822A1 Medicine/gene leaching type stent
09/29/2005WO2005089812A2 Novel antibiotic alternatives
09/29/2005WO2005089811A1 Materials for treating vascular leakage in the eye
09/29/2005WO2005089810A1 Method of inducing bone by transferring human osteogenetic factor gene with the use of electroporation method
09/29/2005WO2005089805A2 Polymer-based compositions and conjugates of hiv entry inhibitors
09/29/2005WO2005089801A1 Method of preventing ultraviolet ray-induced apoptosis
09/29/2005WO2005089791A1 Pea15 as a tumor suppressor gene
09/29/2005WO2005089790A2 Y2/y4 selective receptor agonists for therapeutic interventions
09/29/2005WO2005089789A2 Y2 selective receptor agonists for therapeutic interventions
09/29/2005WO2005089788A1 Medicine for cancer therapy
09/29/2005WO2005089787A1 Use of poly-glu,tyr for treatment of stroke and other disorders
09/29/2005WO2005089786A2 Y4 selective receptor agonists for therapeutic interventions
09/29/2005WO2005089758A1 Methods and compositions for the treatment of conditions related to gastric acid secretion
09/29/2005WO2005089740A1 Coenzyme q composition with long-term persistence in blood
09/29/2005WO2005089724A1 Effervescent formulations comprising desmopressin
09/29/2005WO2005089722A1 Rapid acting drug delivery compositions
09/29/2005WO2005089712A1 Lyophilization method to improve excipient crystallization
09/29/2005WO2005089462A2 Methods and systems for treatment of neurological diseases of the central nervous system
09/29/2005WO2005089398A2 Method for the delivery of sustained release agents
09/29/2005WO2005089386A2 Methods and compositions for using alveolar macrophage phospholipase a2
09/29/2005WO2005089285A2 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
1 ... 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 ... 3163